Inflammation based scores can optimize the selection of patients with advanced cancer considered for early phase clinical trials.

File(s)

An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials..pdf (756.28 KB)

Published version

Show more

Author(s)

Pinato, DJ

Stavraka, C

O'Cathail, SM

Seckl, MJ

Blagden, SP

Type

Journal Article

Date Issued

2012-06

Citation

2012

URI

http://hdl.handle.net/10044/1/13958

DOI

http://dx.doi.org/10.1371/journal.pone.0083279

Start Page

e83279

Journal / Book Title

PLoS One

Volume

9

Issue

1

Copyright Statement

Copyright: © 2014 Pinato et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

License URL

https://creativecommons.org/licenses/by/4.0/

Identifier

http://www.ncbi.nlm.nih.gov/pubmed/24409281

PONE-D-13-34428

Source

48th Annual Meeting of the American-Society-of-Clinical-Oncology

Start Date

2012-06-01

Finish Date

2012-06-05

Coverage Spatial

United States